Jeff Milbrandt, MD, PhD, Molecular, Cellular & Systems Biology Node Leader for NEURO360, pioneering geneticist, and executive director of the McDonnell Genome Institute, has been awarded the inaugural WashU Medicine Dean’s Medal for Innovation and Commercialization, recognizing his transformative discoveries in neurodegeneration and his leadership in translating breakthrough science into therapies.
Read the full announcement on WashU Medicine’s website by clicking here.


